BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36645114)

  • 61. Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort.
    Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Fouladi D; Khoshpouri P; Shao N; Zarghampour M; Hruban RH; Canto M; O'Broin-Lennon AM; Kamel IR
    Eur Radiol; 2018 Jul; 28(7):2790-2800. PubMed ID: 29404774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy.
    Sanders JW; Lewis GD; Thames HD; Kudchadker RJ; Venkatesan AM; Bruno TL; Ma J; Pagel MD; Frank SJ
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1292-1303. PubMed ID: 32634543
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences.
    Storelli L; Pagani E; Rubin M; Margoni M; Filippi M; Rocca MA
    J Magn Reson Imaging; 2024 May; 59(5):1643-1652. PubMed ID: 37530734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
    Sharma K; Caroli A; Quach LV; Petzold K; Bozzetto M; Serra AL; Remuzzi G; Remuzzi A
    PLoS One; 2017; 12(5):e0178488. PubMed ID: 28558028
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
    J Nephrol; 2023 May; 36(4):999-1010. PubMed ID: 36753000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
    Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
    Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
    Irazabal MV; Abebe KZ; Bae KT; Perrone RD; Chapman AB; Schrier RW; Yu AS; Braun WE; Steinman TI; Harris PC; Flessner MF; Torres VE;
    Nephrol Dial Transplant; 2017 Nov; 32(11):1857-1865. PubMed ID: 27484667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kidney volume and function in autosomal dominant polycystic kidney disease.
    Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
    Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease.
    Iijima H; Tada T; Hashimoto M; Nishimura T; Kiriki M; Higashiura A; Iwasaki A; Honda M; Nagasawa Y; Yamakado K
    J Med Ultrason (2001); 2023 Jan; 50(1):81-87. PubMed ID: 36333536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
    O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
    Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; You Z; Gitomer B; Brosnahan G; Torres VE; Chapman AB; Perrone RD; Steinman TI; Abebe KZ; Rahbari-Oskoui FF; Yu ASL; Harris PC; Bae KT; Hogan M; Miskulin D; Chonchol M
    J Am Soc Nephrol; 2018 Feb; 29(2):571-578. PubMed ID: 29118087
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and Evaluation of a Semi-automated Segmentation Tool and a Modified Ellipsoid Formula for Volumetric Analysis of the Kidney in Non-contrast T2-Weighted MR Images.
    Seuss H; Janka R; Prümmer M; Cavallaro A; Hammon R; Theis R; Sandmair M; Amann K; Bäuerle T; Uder M; Hammon M
    J Digit Imaging; 2017 Apr; 30(2):244-254. PubMed ID: 28025731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Geometry-independent assessment of renal volume in polycystic kidney disease from magnetic resonance imaging.
    Turco D; Severi S; Mignani R; Magistroni R; Corsi C
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3081-4. PubMed ID: 26736943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An investigation of the effect of fat suppression and dimensionality on the accuracy of breast MRI segmentation using U-nets.
    Fashandi H; Kuling G; Lu Y; Wu H; Martel AL
    Med Phys; 2019 Mar; 46(3):1230-1244. PubMed ID: 30609062
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
    Cadnapaphornchai MA; Masoumi A; Strain JD; McFann K; Schrier RW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):369-76. PubMed ID: 21115621
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
    Bae K; Park B; Sun H; Wang J; Tao C; Chapman AB; Torres VE; Grantham JJ; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1089-97. PubMed ID: 23520042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deep Learning Assisted Localization of Polycystic Kidney on Contrast-Enhanced CT Images.
    Onthoni DD; Sheng TW; Sahoo PK; Wang LJ; Gupta P
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33371503
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fully Automatic Assessment of Background Parenchymal Enhancement on Breast MRI Using Machine-Learning Models.
    Nam Y; Park GE; Kang J; Kim SH
    J Magn Reson Imaging; 2021 Mar; 53(3):818-826. PubMed ID: 33219624
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.
    Astley JR; Biancardi AM; Hughes PJC; Marshall H; Collier GJ; Chan HF; Saunders LC; Smith LJ; Brook ML; Thompson R; Rowland-Jones S; Skeoch S; Bianchi SM; Hatton MQ; Rahman NM; Ho LP; Brightling CE; Wain LV; Singapuri A; Evans RA; Moss AJ; McCann GP; Neubauer S; Raman B; ; Wild JM; Tahir BA
    J Magn Reson Imaging; 2023 Oct; 58(4):1030-1044. PubMed ID: 36799341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.